Clinical Trial of Deferasirox Combination Treatment With Deferiprone In Thalassaemia Patients

NCT02198508 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Beta-thalassemia Major

Interventions

DRUG: DFX(Deferasirox)
DRUG: DFP(Deferiprone)

Sponsor

China Medical University Hospital